WHO WE ARE
Asia is colorful
and full of opportunity. However, navigating these diverse markets can also be complicated, resource intensive and frustrating without strong local knowledge and infrastructure.
Everlife invests strategically in distribution companies in the region with the aim to provide customers with more complete and advanced medical and laboratory solutions in areas where it matters.
Supplying physicians, researchers and industry professionals with the world’s most trusted brands
Everstone invests in Chemopharm, a leading Southeast Asian distributor of medical products and solutions
Singapore, November 23, 2017 – The Everstone Group via its platform Everlife has acquired Malaysia-based Chemopharm Sdn Bhd., a leading provider of products and services’ solutions to laboratory, research and medical facilities in Southeast Asia. Singapore-based Cure Capital is a co-investor, along with Everstone.
Everstone-backed Everlife invests in Chennai based CPC Diagnostics
Mumbai, March 13, 2019 – The Everstone Group via its healthcare platform Everlife has acquired a stake in Chennai based CPC Diagnostics, to include core in-vitro diagnostics (IVD) segments in its portfolio of medical devices and extend its geographical presence to India, with this first investment in the country.